ProQR Therapeutics (PRQR) Receivables - Other (2013 - 2025)
ProQR Therapeutics recorded quarterly Receivables - Other of $364345.6 in Q4 2025, down 59.17% quarter-over-quarter from $892277.2 in Q4 2024, and down 59.17% year-over-year from $892277.2 in Q4 2024.
ProQR Therapeutics' Receivables - Other history runs 12 years deep, the most recent figure standing at $364345.6 for Q4 2025.
- In Q4 2025, Receivables - Other fell 59.17% year-over-year to $364345.6; the TTM figure through Dec 2025 stood at $364345.6 (down 59.17% YoY), while the FY2025 annual figure was $364345.6, down 59.17% from the prior year.
- Receivables - Other came in at $364345.6 for Q4 2025 at ProQR Therapeutics, down from $892277.2 in the prior quarter.
- In the past five years, Receivables - Other ranged from a high of $892277.2 in Q4 2024 to a low of $306584.2 in Q4 2021.
- A 5-year average of $549475.0 and a median of $382592.8 in 2022 frame the typical range for Receivables - Other.
- Across the five-year window, Receivables - Other surged 109.51% in 2023 and tumbled 59.17% in 2025, its largest moves.
- ProQR Therapeutics' Receivables - Other stood at $306584.2 in 2021, then advanced by 24.79% to $382592.8 in 2022, then soared by 109.51% to $801575.2 in 2023, then climbed by 11.32% to $892277.2 in 2024, then sank by 59.17% to $364345.6 in 2025.
- According to Business Quant data, Receivables - Other over the past three periods registered $364345.6, $892277.2, and $801575.2 for Q4 2025, Q4 2024, and Q4 2023 respectively.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | ProQR Therapeutics | 174.11 Mn | 66.54 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 364,345.62 |
| Dec 31, 2025 | 364,345.62 |
| Dec 31, 2024 | 892,277.16 |
| Dec 31, 2024 | 892,277.16 |
| Dec 31, 2023 | 801,575.23 |
| Dec 31, 2023 | 801,575.23 |
| Dec 31, 2022 | 382,592.76 |
| Dec 31, 2022 | 382,592.76 |
| Dec 31, 2021 | 306,584.21 |
| Dec 31, 2021 | 306,584.21 |
| Dec 31, 2020 | 451,877.85 |
| Dec 31, 2020 | 451,877.85 |
| Dec 31, 2019 | 376,341.81 |
| Dec 31, 2019 | 376,341.81 |
| Dec 31, 2018 | 1.03 Mn |
| Dec 31, 2018 | 1.03 Mn |
| Dec 31, 2017 | 85,952.57 |
| Dec 31, 2017 | 85,952.57 |
| Dec 31, 2016 | 1.26 Mn |
| Dec 31, 2016 | 1.26 Mn |
| Sep 30, 2014 | 254,839.96 |
| Sep 30, 2014 | 254,839.96 |
| Dec 31, 2013 | 80,304.28 |
| Dec 31, 2013 | 80,304.28 |